Global Fund launches key targeted funding round
This article was originally published in Clinica
Executive Summary
The Global Fund to Fight AIDS, Tuberculosis and Malaria today launched the sixth funding round, with a call for proposals and a reminder of the global challenges set for improving care of these diseases. These include achieving universal access to AIDS treatment and prevention by 2010, and halving deaths from tuberculosis and malaria by 2015.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.